UPDATE – Visionary Doubles Down on High-Margin Medical Aesthetics with US$12 Million Exclusive Agreement, Initiates Strategic Exit from Non-Core Businesses

Rhea-AI Summary

Visionary Holdings (NASDAQ: GV) announced a US$12 million exclusive distribution agreement with Huajin China for its flagship Premier Regenerative Complex – President Super Injection, targeting minimum contracted sales within 12 months. The Board approved a divestiture of 100% equity in Visionary Education Services & Management, refocusing the company on medical aesthetics and biotechnology.

Revenue recognition is subject to delivery, customer acceptance, and accounting standards. The company said the moves accelerate commercialization and concentrate capital and management on high-margin regenerative aesthetic products.

Positive

• US$12 million minimum contracted sales target within 12 months
• Board-approved divestiture of 100% equity in Visionary Education Services streamlines operations
• Strategic partnership with Huajin China provides access to a large health and wellness network

Negative

• Revenue from the US$12 million agreement is contingent on delivery and customer acceptance
• Exclusive distribution concentrates commercial risk with a single partner
• Refocusing away from legacy businesses increases dependence on medical aesthetics for near-term revenue

News Market Reaction – GV

-16.59% 4.7x vol

12 alerts

-16.59% News Effect

+3.5% Peak Tracked

-34.7% Trough Tracked

-$789K Valuation Impact

$4M Market Cap

4.7x Rel. Volume

On the day this news was published, GV declined 16.59%, reflecting a significant negative market reaction. Argus tracked a peak move of +3.5% during that session. Argus tracked a trough of -34.7% from its starting point during tracking. Our momentum scanner triggered 12 alerts that day, indicating notable trading interest and price volatility. This price movement removed approximately $789K from the company's valuation, bringing the market cap to $4M at that time. Trading volume was very high at 4.7x the daily average, suggesting heavy selling pressure.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

Exclusive agreement value: US$12 million Contract duration: 12 months Equity transferred: 100% equity interests +2 more

5 metrics

Exclusive agreement value US$12 million Minimum contracted sales target within 12 months

Contract duration 12 months Period for US$12 million minimum sales target

Equity transferred 100% equity interests Sale of Visionary Education Services & Management Inc.

Health centers more than 900 centers Huajin China health and wellness chain centers in China

Geographic footprint over 20 provinces Huajin China operations across China

Market Reality Check

Price: $0.5570 Vol: Volume 77,912 vs 20-day a...

normal vol

$0.5570 Last Close

Volume Volume 77,912 vs 20-day average 72,163 (relative volume 1.08x). normal

Technical Price 0.7075 trades below 200-day MA at 1.56 and at the 52-week low, 92.63% below the 9.6 high.

Peers on Argus

GV fell 4.65% while key education peers were mixed: AMBO down 8.45%, EEIQ up 0.4...

GV fell 4.65% while key education peers were mixed: AMBO down 8.45%, EEIQ up 0.43%, others flat. Moves do not align as a clear sector trend.

Historical Context

5 past events · Latest: Mar 05 (Positive)

Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Mar 05	Growth outlook	Positive	-2.4%	Outlined 2026–2027 growth outlook and RAMU anti-aging sales potential.
Mar 02	Strategic refocus	Positive	-5.1%	Signed US$12M exclusive deal and approved exit from non-core business.
Feb 24	Contract update	Positive	-9.3%	Reported progress on approximately US$9M commercial sales agreement.
Feb 18	China expansion	Positive	-1.8%	Established three new subsidiaries to advance Chinese commercial expansion.
Feb 13	Debt financing	Positive	-0.9%	Secured $450,000 via senior secured convertible promissory note.

Pattern Detected

Recent positive strategic and financing announcements have been followed by consistent negative 24h price reactions.

Recent Company History

Over the past month, Visionary Holdings has reported multiple strategic shifts toward high‑end medical aesthetics and healthcare. Events include a US$9 million sales contract update on Feb 24, 2026, new China subsidiaries for commercialization on Feb 18, 2026, and $450,000 in convertible debt financing on Feb 13, 2026. A growth outlook on Mar 5, 2026 and the earlier US$12 million distribution agreement similarly preceded share price declines, indicating a pattern of negative reactions to ostensibly positive corporate news.

Market Pulse Summary

The stock dropped -16.6% in the session following this news. A negative reaction despite the US$12 m...

Analysis

The stock dropped -16.6% in the session following this news. A negative reaction despite the US$12 million exclusive agreement and strategic divestiture would fit the recent pattern where shares fell after positive announcements. The stock traded at its 52-week low and well below the 200-day MA before this release, suggesting existing skepticism. Past declines following growth guidance and contract news indicate that execution risk and prior disclosures in regulatory filings may continue to weigh on sentiment.

Key Terms

exclusive distribution agreement, equity interests, transfer agent, digital management system, +2 more

6 terms

exclusive distribution agreement financial

"has signed a US$12 million exclusive distribution agreement for its flagship"

A contract in which a manufacturer or rights holder gives one distributor the sole right to sell a product or service in a particular territory or channel. For investors, it matters because exclusivity can boost predictable sales, margin stability and market reach for the parties involved, but it also concentrates risk—if the distributor underperforms or the agreement ends, revenue can drop sharply. Think of it like appointing a single shop to be the only place in town to sell a popular item.

equity interests financial

"approved the transfer of 100% equity interests in Visionary Education Services"

Equity interests are an ownership stake in a company—usually represented by shares or membership units—that give the holder a claim on the business’s profits, assets and sometimes voting power. Think of it as owning one or more slices of a company’s pie: the bigger your slice, the larger your share of dividends, capital gains and influence, and the more you are affected by dilution or company losses. Investors use equity interests to measure value, control and potential returns.

transfer agent financial

"the Board also approved a change in the Company’s transfer agent service provider"

A transfer agent is a financial service that keeps the official record of who owns a company's shares, handles the buying and selling of those shares on paper or electronically, and issues or cancels stock certificates. Think of it as the company’s records keeper and mailroom combined—investors rely on it to make sure dividends, shareholder mailings, ownership changes, and proxy voting are processed accurately and securely, which protects ownership rights and helps prevent errors or fraud.

digital management system technical

"offline service network + digital management system + health product supply chain"

A digital management system is software that organizes and automates a company’s records, workflows and communications—like a centralized control room or smart filing cabinet that keeps information, approvals and tasks in order. Investors care because it can cut costs, reduce mistakes and speed decisions, making operations more efficient, scalable and easier to audit; strong systems can therefore improve profit margins and lower regulatory or operational risk.

light-asset franchise structure technical

"Leveraging a light-asset franchise structure and standardized replication capabilities"

A light-asset franchise structure is a business model where a company builds and controls a brand, systems, or network but deliberately owns few physical assets or heavy operations, instead relying on partners, franchisees, or contractors to run day-to-day activities. For investors this matters because it typically requires less capital, can scale faster and deliver higher margins, but also shifts risk toward partner execution and brand reputation—think of it like running a hotel chain by licensing the name and standards while others own and operate the buildings.

forward-looking statements regulatory

"Cautionary Note Regarding Forward-Looking Statements"

Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.

AI-generated analysis. Not financial advice.

HONG KONG, March 09, 2026 (GLOBE NEWSWIRE) -- Visionary Holdings Inc. (NASDAQ: GV) (“the Company”), a technology-driven multinational enterprise focused on biotechnology and healthcare, today announced that its wholly owned subsidiary, Visionary Health Technology Group Limited (“GV Hong Kong”), has signed a US$12 million exclusive distribution agreement for its flagship anti-aging product, Premier Regenerative Complex-President Super Injection, in cooperation with Huajin China Investment Company（”Huajin China”), alongside the Board-approved divestiture of its non-core business.

These strategic actions mark the Company’s formal transition into a commercialization acceleration phase within the high-end medical aesthetics sector.

Commercialization Milestone for Premier Regenerative Complex – President Super Injection
The Company’s wholly owned subsidiary, Visionary Health Technology Group Limited, has entered into an exclusive distribution agreement with Huajin China, establishing a minimum contracted sales target of US$12 million within a 12-month period. Revenue recognition will be subject to product delivery, customer acceptance, and applicable accounting standards.

This agreement represents a significant step in scaling the commercial deployment of Premier Regenerative Complex – President Super Injection, reflecting growing market acceptance and strengthening revenue visibility.

Strategic Divestiture to Concentrate on Core Medical Aesthetics Track
On February 27, 2026, the Company’s Board of Directors approved the transfer of 100% equity interests in Visionary Education Services & Management Inc. to Cai Dao Trading Ltd., completing the planned exit from non-core legacy business operations. In addition, in light of the Company’s evolving business development needs, the Board also approved a change in the Company’s transfer agent service provider.

Following this divestiture, Visionary Holdings will operate as a streamlined biotechnology and healthcare-focused enterprise, allocating capital, technology and management resources exclusively toward:

• Anti-aging injectable products
• Regenerative medical aesthetics
• Biotechnology-driven healthcare innovation
  

The product is intended for aesthetic and wellness applications and is not intended to diagnose, treat, cure, or prevent any disease.

Management Commentary

Xiyong Hou, Chief Executive Officer of Visionary Holdings, commented:

“With the completion of our core business refocusing and asset structure optimization, the Company is formally entering a more focused and execution-driven growth phase within the global medical aesthetics market.

Over the past several years, we have undertaken extensive strategic evaluation and operational refinement to identify the most scalable and value-accretive direction for Visionary Holdings. Through disciplined analysis and market validation, we have established medical aesthetics and regenerative injectable products as our long-term core growth engine.

The signing of this exclusive distribution agreement for Premier Regenerative Complex – President Super Injection™ represents not only a significant commercialization milestone, but also the beginning of a new execution-centered growth cycle. At the same time, the divestiture of our non-core assets materially enhances our capital efficiency and strengthens our financial flexibility.

By concentrating resources on high-margin, high-growth medical aesthetics and biotechnology-driven healthcare innovation, we believe the Company is entering a structured growth cycle characterized by improved revenue visibility, stronger operational focus, and enhanced financial capacity to support sustainable expansion.”

About Huajin China Investment Company

Huajin China is an industry-focused operating platform dedicated to community-based smart elderly care and senior health management. The Company has established more than 900 health and wellness chain centers across over 20 provinces in China, forming an integrated “offline service network + digital management system + health product supply chain” operating model. Leveraging a light-asset franchise structure and standardized replication capabilities, Huajin has strategically expanded into China’s county-level elderly care markets while advancing the digital transformation of smart home-based senior care services. Looking ahead, the Company aims to drive industry consolidation and capital market integration to become a leading AI-driven digital elderly care platform in the Asia-Pacific region.

About Visionary Holdings Inc.
Visionary Holdings Inc. (Nasdaq: GV) is a technology-driven multinational enterprise focused on AI applications, and high-tech healthcare solutions. Headquartered in Toronto, Canada, the Company operates through its subsidiaries across North America and Asia, driving technological advancement, cross-border innovation, and global health transformation.

Cautionary Note Regarding Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934 and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will", "expects", "anticipates", "future", "intends", "plans", "believes", "estimates", "target", "going forward", "outlook," "objective" and similar terms. Such statements are based upon management's current expectations and current market and operating conditions, and relate to events that involve known or unknown risks, uncertainties and other factors, all of which are difficult to predict and which are beyond GV's control, which may cause GV's actual results, performance or achievements (including the RMB/USD value of its anticipated benefit to GV as described herein) to differ materially and in an adverse manner from anticipated results contained or implied in the forward-looking statements. Further information regarding these and other risks, uncertainties or factors is included in GV's filings with the U.S. Securities and Exchange Commission, which are available at www.sec.gov. GV does not undertake any obligation to update any forward-looking statement as a result of new information, future events or otherwise, except as required under law.

Contacts:

Visionary Holdings Inc.
Investor Relations
Email: IR@visionary.holdings

FAQ

What does Visionary Holdings (GV) agreement with Huajin China entail and how much is it worth?

It is an exclusive distribution agreement with a minimum contracted sales target of US$12 million over 12 months. According to the company, the contract establishes commercialization terms but revenue depends on product delivery and customer acceptance under applicable accounting standards.

How does the February 27, 2026 divestiture affect Visionary Holdings (GV) strategy?

The Board approved transfer of 100% equity in Visionary Education Services, shifting GV to a streamlined biotech and healthcare focus. According to the company, capital, technology, and management resources will be reallocated to anti-aging injectables and regenerative medical aesthetics.

When will Visionary (GV) recognize revenue from the Premier Regenerative Complex sales?

Revenue recognition will occur after product delivery, customer acceptance, and per accounting rules. According to the company, the US$12 million contracted sales target is subject to these conditions and recognized in line with applicable accounting standards.

What commercial reach does Huajin China offer for Visionary's Premier Regenerative Complex under the GV deal?

Huajin China operates over 900 health and wellness centers across 20+ provinces, offering an offline network plus digital management and product supply chain. According to the company, this distribution footprint supports scaled commercialization in China’s county-level and senior-care markets.

What are the main risks for Visionary Holdings (GV) after refocusing on medical aesthetics?

Primary risks include dependency on a single exclusive distributor and conditional revenue recognition for the US$12 million target. According to the company, these moves increase commercial concentration while aiming to improve revenue visibility and capital efficiency.